Anti-OX40 Antibody PF-04518600 Uses, Dosage, Side Effects and more
Anti-OX40 Antibody PF-04518600 is under investigation in clinical trial NCT02554812 (A Study of Avelumab in Combination With Other Cancer Immunotherapies in Advanced Malignancies (JAVELIN Medley)).
| Trade Name | Anti-OX40 Antibody PF-04518600 |
| Generic | Ivuxolimab |
| Ivuxolimab Other Names | Anti-OX40 Antibody PF-04518600, Ivuxolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
